ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

MD Anderson Faculty Slam Leadership, Question Moon Shots, Bemoan Workload

March 29, 2013

ACR Defends Mammographic Exams For Women 35-40,Says Carcinogenic Threat Is “Small”

July 30, 1976

ACS Expresses Concern About “Fletcher Report” On Mammography

May 7, 1993

Niederhuber Says Resignation “Pro Forma,” Hopes To Stay As Director Or Lab Chief.

December 19, 2008

NCAB Subcommittee Worries About Board’s Makeup

January 19, 1979

Dismissed Leukemia Drug Helps CLL, Clinical Trials Find

December 26, 2008